Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 52
Selected: 0
NCT IDTitle
NCT03362242Study of ARO-AAT in Normal Adult Volunteers
NCT02797522A Study of ARC-521 Injection in Normal Adult Volunteers and Patients With Chronic Hepatitis B (CHB)
NCT05902598A Phase 3 Study of ARO-APOC3 / VSA001 / SAR449124 (Plozasiran) in Chinese Adults With Familial Chylomicronemia Syndrome
NCT04202354Study of ARO-HSD in Healthy Volunteers and Patients With Non-Alcoholic Steatohepatitis (NASH) or Suspected NASH
NCT06209177Study of ARO-CFB in Adult Healthy Volunteers
NCT03747224Study of ARO-ANG3 in Healthy Volunteers and in Dyslipidemic Patients
NCT03946449Study of Fazirsiran (TAK-999, ARO-AAT) in Patients With Alpha-1 Antitrypsin Deficiency Associated Liver Disease (AATD)
NCT04720534Study to Evaluate ARO-APOC3 in Adults With Severe Hypertriglyceridemia
NCT07241546Study of Inhaled ARO-RAGE in Allergen-induced Mild Asthma
NCT05083364Study of ARO-C3 in Adult Healthy Volunteers and Patients With Complement Mediated Renal Disease
NCT05757596Study of VSA001 Injection in Chinese Healthy Adult Volunteers
NCT07473843Study of Zodasiran in Adolescent Participants With Homozygous Familial Hypercholesterolemia
NCT02363946A Study of ARC-AAT in Healthy Volunteer Subjects and Patients With Alpha-1 Antitrypsin Deficiency (AATD)
NCT05949294Study of AROSOD-1 in Adult Participants With Amyotrophic Lateral Sclerosis (ALS)
NCT06700538A First-In-Human Study of ARO-INHBE in Adults With Obesity With and Without Type 2 Diabetes Mellitus
NCT02065336A Multicenter Study to Determine the Depth and Duration of Hepatitis B Surface Antigen (HBsAg) Reduction After Single or Multiple Doses of ARC-520, in Combination With Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection
NCT05217667Study of ARO-ANG3 in Participants With Homozygous Familial Hypercholesterolemia (HOFH)
NCT05413135Study of ARO-APOC3 in Adults With Dyslipidemia
NCT02577029Study of ARC-520 With or Without Other Drugs Used in the Treatment of Chronic Chronic Hepatitis B Virus (HBV)
NCT02900183Safety, Tolerability and Effect of ARC-AAT Injection on Circulating and Intrahepatic Alpha-1 Antitrypsin Levels
NCT01872065Safety and Tolerability Study of ARC-520 in Healthy Volunteers
NCT02349126Study of ARC-520 in Patient With Chronic Hepatitis B Virus
NCT06347003Study of Plozasiran (ARO-APOC3) in Adults With Severe Hypertriglyceridemia
NCT06880770Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis
NCT03783377Study of ARO-APOC3 in Healthy Volunteers, Hypertriglyceridemic Patients and Patients With Familial Chylomicronemia Syndrome (FCS)
NCT02452528Study of ARC-520 in Participants With Hepatitis B Virus e Antigen (HBeAg) Positive Chronic Hepatitis B Virus
NCT06347133Phase 3 Study of Plozasiran in Adults With Hypertriglyceridemia
NCT02535416A Study of ARC-520 at Varying Infusion Rates in Healthy Adult Volunteers
NCT04169711Study of ARO-HIF2 in Patients With Advanced Clear Cell Renal Cell Carcinoma
NCT05276570Study of ARO-RAGE in Healthy Subjects and Patients With Inflammatory Lung Disease
NCT07223658Study of ARO-DIMERPA in Adult Participants With Mixed Hyperlipidemia
NCT06131983Study of ARO-DUX4 in Adult and Adolescent Patients With Facioscapulohumeral Muscular Dystrophy Type 1
NCT05292950Study of ARO-MUC5AC in Healthy Subjects and Patients With Muco-Obstructive Lung Disease
NCT06347016Study of Plozasiran in Adults With Severe Hypertriglyceridemia
NCT03945292Safety, Tolerability and Pharmacodynamic Effect of Fazirsiran (TAK-999, ARO-AAT)
NCT05533294Study of ARO-RAGE in Healthy Subjects
NCT06672445Study of ARO-ATXN2 Injection in Adults With Spinocerebellar Ataxia Type 2
NCT02738008Extension Study of the Safety and Efficacy of Multi-dose Intravenous ARC-520 in Patients With Chronic Hepatitis B (HBV) Infection
NCT06937203A First-In-Human Study of ARO-ALK7 in Adults With Obesity With and Without Type 2 Diabetes Mellitus
NCT05089084Study of ARO-APOC3 (Plozasiran) in Adults With Familial Chylomicronemia Syndrome (FCS)
NCT02604199A Multi-dose Study of ARC-520 in Patients With Hepatitis B 'e' Antigen (HBeAg) Negative, Chronic Hepatitis B Virus (HBV) Infection
NCT04998201Study of Plozasiran (ARO-APOC3) in Adults With Mixed Dyslipidemia
NCT02604212A Multi-dose Study of ARC-520 in Patients With Hepatitis B 'e' Antigen (HBeAg) Positive, Chronic Hepatitis B Virus Infection
NCT06138743Study of ARO-DM1 in Subjects With Type 1 Myotonic Dystrophy
NCT05537025Study of ARO-MMP7 Inhalation Solution in Healthy Subjects and Patients With Idiopathic Pulmonary Fibrosis
NCT06796426Treatment Protocol of Plozasiran in Adults With High-Risk Severe Hypertriglyceridemia (SHTG) and in Adults and Adolescents With FCS
NCT07037771A Phase 3 Study of Zodasiran in Adolescent and Adult Subjects With Homozygous Familial Hypercholesterolemia (YOSEMITE)
NCT04375514Study of ARO-ENaC in Healthy Volunteers and in Patients With Cystic Fibrosis
NCT07221344Study of ARO-MAPT-SC in Healthy Subjects and Subjects With Early Alzheimer's Disease
NCT04832971Study of ARO-ANG3 in Adults With Mixed Dyslipidemia